Wnt genes in colonic polyposis predisposition.

Autor: Quintana I; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Terradas M; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Mur P; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain., Te Paske IBAW; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., Peters S; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Spier I; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Steinke-Lange V; Member of SOLVE-RD ERN-GENTURIS.; Medizinische Klinik Und Poliklinik IV, Campus Innenstadt, Klinikum Der Universität München, Munich 80336, Germany.; MGZ - Medizinisch Genetisches Zentrum, Munich 80335, Germany., Maestro C; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Torrents D; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain.; ICREA, Barcelona 08010, Spain., Puiggròs M; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain., Royo R; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain., Tonda R; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Parra G; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Piscia D; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Beltrán S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain.; Universitat Pompeu Fabra (UPF), Barcelona 08002, Spain.; Department of Genetics, Microbiology and Statistics, School of Biology, Universitat de Barcelona (UB), Barcelona 08028, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain., Piñol V; Gastroenterology Unit, Hospital Universitario de Girona Dr Josep Trueta, Girona 17007, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Catalan Institute of Oncology, IDIBGi, Girona 17007, Spain., Gonzalez-Abuin N; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Aiza G; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Sommer A; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., van Herwaarden Y; Member of SOLVE-RD ERN-GENTURIS.; Department of Gastroenterology and Hepatology, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands., Astuti G; Member of SOLVE-RD ERN-GENTURIS.; Department of Human Genetics, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands., Holinski-Feder E; Member of SOLVE-RD ERN-GENTURIS.; Medizinische Klinik Und Poliklinik IV, Campus Innenstadt, Klinikum Der Universität München, Munich 80336, Germany.; MGZ - Medizinisch Genetisches Zentrum, Munich 80335, Germany., Hoogerbrugge N; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., de Voer RM; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., Aretz S; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Member of SOLVE-RD ERN-GENTURIS., Valle L; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Member of SOLVE-RD ERN-GENTURIS.

Publikováno v: Genes & diseases [Genes Dis] 2022 Dec 29; Vol. 10 (3), pp. 753-757. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).

High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

Autor: Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association

Publikováno v: Endoscopy
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Background Serrated polyposis syndrome (SPS) has been associated with an increased risk of colorectal cancer (CRC). Accordingly, intensive surveillance with annual colonoscopy is advised. The aim of this multicenter study was to describe the risk of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::160a3b9ef7e9da8f0338a1c77f43431d
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3955

Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.

Autor: Sánchez A; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Roos VH; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Navarro M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Pineda M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Caballol B; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Moreno L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Carballal S; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Rodríguez-Alonso L; Department of Gastroenterology, Hospital Universitari de Bellvitge, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain., Ramon Y Cajal T; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Llort G; Department of Medical Oncology and Gastroenterology, Parc Tauli Hospital Universitari, Conscorci Sanitari de Terrasa, Sabadell-Terrasa, Spain., Piñol V; Department of Gastroenterology, University of Girona, Hospital Dr Josep Trueta, Girona, Spain., López-Fernández A; Department of Medical Oncology, Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Salces I; Department of Gastroenterology, Hospital 12 de Octubre, Madrid, Spain., Picó MD; Department of Gastroenterology, Hospital General Universitario de Elche, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Elche, Spain., Rivas L; Department of Gastroenterology, Complexo Hospitalario Universitario de Orense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Ourense, Spain., Bujanda L; Department of Gastroenterology, Biodonostia Health Research Institute, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián, Spain., Garzon M; Department of Gastroenterology, Hospital Virgen del Rocio, Sevilla, Spain., Pizarro A; Department of Gastroenterology, Hospital Virgen del Rocio, Sevilla, Spain., Martinez de Castro E; Department of Medical Oncology and Gastroenterology, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Santander, Spain., López-Arias MJ; Department of Medical Oncology and Gastroenterology, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Santander, Spain., Poves C; Department of Gastroenterology, Hospital Clínico San Carlos, Madrid, Spain., Garau C; Department of Gastroenterology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain., Rodriguez-Alcalde D; Department of Gastroenterology, Hospital de Móstoles, Móstoles, Spain., Herraiz M; Department of Gastroenterology, Clínica Universidad de Navarra, Pamplona, Spain., Alvarez-Urrutia C; Department of Gastroenterology, Institut Hospital del Mar d'Investigacions Biomèdiques (IMIM), Hospital del Mar Medical Research Institute, Barcelona Hospital del Mar, Barcelona; Spain., Dacal A; Department of Gastroenterology, Hospital Universitario Lucus Augusti, Lugo, Spain., Carrillo-Palau M; Department of Gastroenterology, Hospital Universitario de Canarias, Tenerife, Spain., Cid L; Department of Gastroenterology, Xerencia Xestion Integrada de Vigo, Servizo Galego de Saude (SERGAS), Research Group in Digestive Diseases, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), SERGAS-Universidade de Vigo (UVIGO), Vigo, Spain., Ponce M; Department of Gastroenterology, Hospital Universitario de la Fe de Valencia, Valencia, Spain., Barreiro-Alonso E; Department of Gastroenterology, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain., Saperas E; Department of Gastroenterology, Hospital Universitari General de Catalunya, Sant Cugat, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain., Aguirre E; Genetic Counseling Unit, Department of Medical Oncology, Hospital Quirónsalud Zaragoza, Zaragoza, Spain., Romero C; Department of Medical Oncology and Gastroenterology, Parc Tauli Hospital Universitari, Conscorci Sanitari de Terrasa, Sabadell-Terrasa, Spain., Bastiaansen B; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Gonzalez-Acosta M; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Morales-Romero B; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Ocaña T; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Rivero-Sánchez L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Jung G; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Bessa X; Department of Gastroenterology, Institut Hospital del Mar d'Investigacions Biomèdiques (IMIM), Hospital del Mar Medical Research Institute, Barcelona Hospital del Mar, Barcelona; Spain., Cubiella J; Department of Gastroenterology, Complexo Hospitalario Universitario de Orense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Ourense, Spain., Jover R; Department of Gastroenterology, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica ISABIAL, Alicante, Spain., Rodríguez-Moranta F; Department of Gastroenterology, Hospital Universitari de Bellvitge, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain., Balmaña J; Department of Medical Oncology, Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigacio Biomèdica de Giron Dr. Josep Trueta (IDIBGI), Medical Sciences Department, School of Medicine, University of Girona, Hospital Dr Josep Trueta, Girona, Spain., Castells A; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Capella G; Hereditary Cancer Program, Oncobell Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospital Duran i Reynals., Serra-Burriel M; Center for Research in Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain., Moreira L; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Pellise M; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Balaguer F; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. Electronic address: fprunes@clinic.cat.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Mar; Vol. 20 (3), pp. 611-621.e9. Date of Electronic Publication: 2020 Nov 03.

Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

Autor: Egoavil C, Juarez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R

Publikováno v: GASTROENTEROLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

BACKGROUND & AIMS: We investigated whether patients with multiple serrated polyps, but not meeting the World Health Organization criteria for serrated polyposis syndrome, and their relatives have similar risks for colorectal cancer (CRC) as those dia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::51850a81cba000ddcae09d1915052005
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1954

Non-Lynch Familial and Early-Onset Colorectal Cancer Explained by Accumulation of Low-Risk Genetic Variants.

Autor: Mur P; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Bonifaci N; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain., Díez-Villanueva A; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain., Munté E; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain., Alonso MH; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain., Obón-Santacana M; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain., Aiza G; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Piñol V; Gastroenterology Unit, Hospital Universitario de Girona Dr Josep Trueta, 17007 Girona, Spain.; School of Medicine, University of Girona, 17071 Girona, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; School of Medicine, University of Girona, 17071 Girona, Spain.; Catalan Institute of Oncology, IDIBGi, 17007 Girona, Spain., Tomlinson I; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh EH4 2XR, UK., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Moreno V; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain., Valle L; Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2021 Jul 31; Vol. 13 (15). Date of Electronic Publication: 2021 Jul 31.